id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0902-0008,FDA,FDA-2011-N-0902,"Agency Information Collection Activities; Proposed Collection;
Submission for Office of Management and Budget Review; Prescription Drug Product Labeling; Medication Guide Requirements",Notice,30 Day Proposed Information Collection,2015-11-03T05:00:00Z,2015,11,2015-11-03T05:00:00Z,2015-12-04T04:59:59Z,2015-11-03T15:22:04Z,2015-27945,0,0,0900006481d07075
FDA-2011-N-0902-0006,FDA,FDA-2011-N-0902,"Agency Information Collection Activities; Proposed Collection; 
Comment Request; Prescription Drug Product Labeling; Medication Guide Requirements",Notice,60 Day Proposed Information Collection,2015-05-29T04:00:00Z,2015,5,2015-05-29T04:00:00Z,2015-07-29T03:59:59Z,2015-10-26T13:41:26Z,2015-12976,0,0,0900006481b0ccdd